好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Presentation, Causes, and Hemodynamic Features of Acquired Afferent Baroreflex Failure
Neuromuscular and Clinical Neurophysiology (EMG)
S19 - Autonomic Disorders (3:54 PM-4:06 PM)
003

To review the presentation, causes, and hemodynamic characteristics of patients with acquired afferent baroreflex failure. 

Damage to the vagus and/or glossopharyngeal nerves, or the nucleus of the solitary tract in the brainstem results in acquired afferent baroreflex failure, characterized by excessive blood pressure fluctuations.

Retrospective chart review of the presentation, causes, and hemodynamic and neuroendocrine characteristics of all cases with acquired afferent baroreflex failure in the NYU Patient Registry. Data included comprehensive medical history, neurological examinations, standardized autonomic testing, and ambulatory 24-hour blood pressure monitoring.

Among 2,875 subjects in the NYU Patient Registry, we identified 17 patients (13 men, 4 women, aged 22-74 years at diagnosis) with acquired afferent baroreflex failure. Etiology included radiotherapy-induced damage to IX and X cranial nerves in the context of head and neck cancer (HPV-related squamous cell carcinoma or nasopharyngeal carcinoma) (n=11), surgical resection of brainstem neoplasia (n=2), paraganglioma (n=1), ganglioneuroma (n=1), carotid endarterectomy (n=1), or idiopathic (n=1). Presentation included labile blood pressure, blushing, headache, lightheadedness, and syncope. All patients had significant pressor and tachycardic responses to cognitive stress (e.g., mental calculations or discussing emotional or upsetting topics). Systolic blood pressure was very labile with maximum and minimum of 190±28.85 and 83.3±17.7 mmHg, respectively. All patients had orthostatic hypotension. Plasma norepinephrine levels in the supine position were 455± 254 pg/mL increasing to only 632±198 pg/ml after 10-mins of head-up tilt; and plasma vasopressin levels in the supine position were 0.65±0.21 pg/mL increasing to only 1.6±0.67 pg/ml after 10-mins of head-up tilt.

This is the largest series of patients with acquired afferent baroreflex failure reported to date. The syndrome of acquired afferent baroreflex failure should be considered in patients presenting with labile blood pressure and a history suggesting damage to the glossopharyngeal and vagus nerves.  
Authors/Disclosures
Bhumika Balgobin, MD (NYU Langone Ambulatory Care East Meadow)
PRESENTER
No disclosure on file
Jose-Alberto Palma, MD, PhD, FAAN (New York University Grossman School of Medicine) Dr. Palma has received personal compensation for serving as an employee of Novartis. Dr. Palma has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Autonomic Research. The institution of Dr. Palma has received research support from National Institutes of Health. Dr. Palma has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
Horacio C. Kaufmann, MD, FAAN (NYU Langone Health - NYU Dysautonomia Center) Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parexel. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.